Erratum: A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture (Toxicolological Sciences (2006) vol. 93 (156-163) 10.1093/toxsci/kfl045);A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture

Toxicological Sciences

Volumn 93, Issue 1, 2006, Pages 156-163

  Bhuller, Yadvinder ^a,c   Wells, Peter G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HEALTH CANADA   (Canada)

Author keywords

Ataxia telangiectasia; Atm; Development; Developmental toxicology; Embryopathy; Oxidative stress; Phenytoin; Reactive oxygen species

Indexed keywords

ATM PROTEIN; PHENYTOIN; REACTIVE OXYGEN METABOLITE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DAMAGE; EMBRYO; EMBRYO CULTURE; EMBRYOPATHY; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; IMMUNOPRECIPITATION; IN VIVO STUDY; IONIZING RADIATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; TERATOGENESIS; WESTERN BLOTTING; WILD TYPE;

ATAXIA TELANGIECTASIA;

EID: 33747894202     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl086     Document Type: Erratum

References (33)

1. Andegeko, Y., Moyal, L., Mittelman, L., Tsafraty, I., Shiloh, Y., and Rotman, G. (2001). Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276, 38224-38230.
2. Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998). Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677.
3. Barlow, C., Ribaut-Barasin, C., Zwingman, T. A., Pope, A. J., Brown, K. D., Owens, J. W., Larson, D., Harrington, E. A., Haeberle, A. M., Mariani, J., et al. (2000). ATM is a cytosolic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl. Acad. Sci. U.S.A. 97, 871-876.
4. Bhuller, Y., Jeng,W., and Wells, P. G. (2006). Variable in vivo embryoprotective role for ataxia telangiectasia-mutated (Atm)against constitutive and phenytoin-enhanced oxidative stress in Atm knockout mice. Toxicol. Sci. 93, 146-155.
5. Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Apella, E., Kavtan, M. B., and Siliciano, J. D. (1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679.
6. Herzog, K. H., Chong, M. J., Kapsetaki, M., Morgan, J. I., and McKinnon, P. J. (1998). Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280, 1089-1091.
7. Heyer, B., MacAuley, A., Behrendtsen, O., and Werb, Z. (2000). Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14, 2072-2084.
8. Kamsler, A., Daily, D., Hochman, A., Stern, N., Shiloh, Y., Rotman, G., and Barzilai, A. (2001). Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61, 1849-1854.
9. Kennedy, J. C., Memet, S., and Wells, P. G. (2004). Antisense evidence for NFkB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress. Mol. Pharmacol. 66, 404-412.
10. Komarova, E. A., Chernov, M. V., Franks, R., Wang, K., Armin, G., Zelnick, C. R., Chin, D. M., Bacus, S. S., Stark, G. R., and Gudkov, A. V. (1997). Transgenic mice with p53-responsive lacZ: P53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16, 1391-1400.
11. Kuljis, R. O., Xu, Y., Aguila, M. C., and Baltimore, D. (1997). Degeneration of neurons, synapses, and neurophil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc. Natl. Acad. Sci. U.S.A. 94, 12688-12693.
12. Laposa, R. R., Henderson, J. T., Xu, E., andWells, P. G. (2004). Atm-null mice exhibit enhanced radiation-induced birth defects and a hybrid form of embryonic programmed cell death indicating a teratological suppressor function for ATM. FASEB J. 18, 896-898.
13. Meyn, M. S. (1999). Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin. Genet. 55, 289-304.
14. Moallem, S. A., and Hales, B. F. (1998). The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development 125, 3225-3234.
15. Nicol, C. J., Harrison, M. L., Laposa, R. R., Gimelshtein, I. L., and Wells, P. G. (1995). A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet. 10, 181-187.
16. Nicol, C. J., Zielenski, J., Tsui, L. C., and Wells, P. G. (2000). An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J. 14, 111-127.
17. Oka, A., and Takashima, S. (1998). Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci. Lett. 252, 195-198.
18. Pandita, T. K., and Hittleman, W. N. (1992). Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. Radiat. Res. 130, 94-103.
19. Parman, T., Chen, G., and Wells, P. G. (1998). Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis. J. Biol. Chem. 273, 25079-25088.
20. Quick, K. L., and Dugan, L. L. (2001). Superoxide stress identifies neurons at risk in model of ataxia-telangiectasia. Ann. Neurol. 49, 627-635.
21. Rotman, G., and Shiloh, Y. (1999). ATM: A mediator of multiple responses to genotoxic stress. Oncogene 18, 6135-6144.
22. 46, in response to ionizing radiation. J. Biol. Chem. 277, 12491-12494.
23. Shiloh, Y. (2001). ATM and ATR: Networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 15, 2177-2196.
24. Smilenow, L. B, Brenner, D. J., and Hall, E. J. (2001). Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells. Cancer Res. 61, 5710-5713.
25. Suzuki, K., Kodama, S., andWatanabe,M. (1999). Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J. Biol. Chem. 274, 25571-25575.
26. Thacker, J. (1994). Cellular radiosensitivity in ataxia-telangiectasia. Int. J. Radiat. Biol. 66, S87-S96.
27. Vinson, R. K., and Hales, B. F. (2003). Genotoxic stress response gene expression in the mid-organogenesis rat conceptus. Toxicol. Sci. 74, 157-164.
28. Wells, P. G., Bhuller, Y., Chen, C. S., Jeng,W., Kasapinovic, S., Kennedy, J. C., Kim, P. M., Laposa, R. R., McCallum, G. P., Nicol, C. J., et al. (2005). Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol. Appl. Pharmacol. 207(Suppl. 2S), 348-359.
29. Winn, L. M., and Wells, P. G. (1995). Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: Evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol. Pharmacol. 48, 112-120.
30. Winn, L. M., and Wells, P. G. (1997). Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Free Radic. Biol. Med. 22, 607-621.
31. Winn, L. M., and Wells, P. G. (1999). Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Radic. Biol. Med. 26, 266-274.
32. Winn, L. M., and Wells, P. G. (2002). Evidence for Ras-dependent signal transduction in phenytoin teratogenicity. Toxicol. Appl. Pharmacol. 184, 144-152.
33. Wong, A. W., and Wells, P. G. (2002). p53 modulation of phenytoin embryopathies in p53 knockout mice. Toxicol. Sci. (Suppl. Toxicologist) 66, 28 (Abstract 131).